FORE(301368)2025-04-23 12:25Financial Performance - The company's revenue for Q1 2025 was ¥116,571,485.72, representing an increase of 18.20% compared to ¥98,625,884.61 in the same period last year[5]. - Net profit attributable to shareholders decreased by 35.98% to ¥2,938,656.40 from ¥4,590,201.26 year-on-year[5]. - The company reported a basic earnings per share of ¥0.02, down 50.00% from ¥0.04 in the same period last year[5]. - Net profit for the current period was ¥2,938,656.40, a decrease of 36.0% from ¥4,590,201.26 in the previous period[20]. - The total equity attributable to shareholders of the parent company was ¥979,869,606.54, slightly up from ¥976,683,948.45[18]. - Other comprehensive income after tax for the current period was ¥247,001.69, compared to a loss of ¥181,441.95 in the prior period[20]. Cash Flow and Liquidity - The net cash flow from operating activities was negative at -¥3,737,560.16, a significant decline of 1,582.44% compared to -¥222,150.63 in the previous year[5]. - Cash flow from operating activities generated ¥119,890,332.77, compared to ¥112,351,536.62 in the previous period[22]. - The net increase in cash and cash equivalents was 6,982,244.80, a significant recovery from a decrease of -58,833,055.37 in the prior period[24]. - The ending balance of cash and cash equivalents stood at 110,271,563.77, compared to 227,403,322.34 at the beginning of the period, showing a decrease in liquidity[24]. - The company received tax refunds totaling 9,302,478.57, an increase from 6,473,640.78, contributing positively to cash flow[23]. Assets and Liabilities - Total assets increased by 8.73% to ¥1,429,736,076.43 from ¥1,314,959,663.58 at the end of the previous year[5]. - Current assets increased to CNY 538,886,474.89 from CNY 507,541,133.92, representing a growth of about 6.5%[15]. - The company’s total liabilities increased, with accounts payable rising to CNY 167,671,930.31 from CNY 147,356,075.22, an increase of approximately 13.8%[15]. - The total liabilities increased to ¥449,866,469.89 from ¥338,275,715.13, reflecting a growth of 33.0%[18]. - The company’s non-current assets totaled CNY 890,849,601.54, up from CNY 807,418,529.66, indicating a growth of about 10.3%[15]. Operational Efficiency - The company experienced a significant increase in receivables financing, up 1,809.19% to ¥555,569.85 due to higher bank acceptance bills[9]. - Short-term borrowings rose by 161.34% to ¥159,146,206.06, attributed to increased funding needs due to company expansion[9]. - Total operating costs amounted to ¥114,763,551.28, up 18.7% from ¥96,677,340.21 in the prior period[19]. - Research and development expenses were ¥3,808,114.53, an increase from ¥3,603,558.84 year-over-year[19]. - Payments to employees increased to 24,901,740.79 from 22,048,739.47, reflecting higher labor costs[23]. - Cash outflow for other operating activities rose to 7,017,636.70 from 4,830,510.01, indicating increased operational expenses[23]. Strategic Developments - The company entered a strategic partnership with Beijing Xingdong Jiyuan Technology Co., focusing on humanoid robots and related components, aiming to enhance operational efficiency and market share[12]. - The company did not execute any significant acquisitions or new product launches during this reporting period, focusing instead on stabilizing cash flow[25]. - The company has not reported any changes in the number of preferred shareholders or any significant changes in shareholding structure[12].